Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Robert Y. Osamura"'
Publikováno v:
Case Reports in Pathology, Vol 2017 (2017)
Mixed neuroendocrine-nonneuroendocrine neoplasm (MiNEN) is defined as mixed epithelial neoplasms composed of both neuroendocrine and nonneuroendocrine components with variable proportions for each component. Neuroendocrine component can show morpholo
Externí odkaz:
https://doaj.org/article/60f845c781a6449dac979bdbce5999e5
Autor:
Thong Quang Pham, Shinsuke Aida, Ichiro Mori, Takeo Koshida, Takashi Ohigashi, Katsuyoshi Katase, Fumiyoshi Murakami, Thong Minh Tran, Robert Y. Osamura
Publikováno v:
Case Reports in Pathology, Vol 2013 (2013)
Solitary fibrous tumour is a soft tissue tumour composed of a subset of fibroblast-like cells and frequently needs immunohistochemical staining for final diagnosis. Epithelioid angiomyolipoma is a variant of angiomyolipoma but characterized by the ab
Externí odkaz:
https://doaj.org/article/67f84f1427a54226aa0281b86443e9cb
Autor:
Josef Rüschoff, Alexander Penner, Ian O. Ellis, M. Elizabeth H. Hammond, Annette Lebeau, Robert Y. Osamura, Frédérique Penault-Llorca, Federico Rojo, Neil Atkey, Andreas H. Scheel, Corrado D´Arrigo, Hans-Ulrich Schildhaus, Akira Moh, Chirag Desai, Giuseppe Viale
Publikováno v:
Cancer Research. 83:HER2-13
Background: Based on the results of the DESTINY-Breast04 study, the HER2-targeted antibody-drug conjugate trastuzumab deruxtecan (T-DXd) and the Ventana PATHWAY 4B5 companion diagnostic were recently approved by the US Food and Drug Administrated for
Publikováno v:
Endocrine Pathology. 33:6-26
Publikováno v:
Hormones. 21:1-14
Autor:
Robert Y. Osamura
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM.
Autor:
Akira Matsuno, Akira Teramoto, Robert Y Osamura, Shigeyuki Tahara, Chie Inomoto, Kenichi Oyama, Midori Kimura
Publikováno v:
Brain Tumor Pathology. 38:183-188
In 2017, WHO published an updated classification of the pituitary adenomas according to the lineages defined by the transcription factors, PIT1, SF1 and TPIT. Nomenclature of the pituitary tumors follows the mature cell types such as somatotroph (GH)
Autor:
Robert Y. Osamura, Chie Inomoto, Shigeyuki Tahara, Ken-ichi Oyama, Akira Matsuno, Akira Teramoto
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM.
Crooke cell change was first found in the regressed and suppressed corticotroph (adrenocorticotropic hormone-producing) cells, and now is known to occur in pituitary tumors. The tumor cells of this type can be recognized by morphology with immunohist
Publikováno v:
Hormones (Athens, Greece). 21(1)
High-risk pituitary adenomas are aggressive. They show clinical and imaging features similar to those of carcinomas, including infiltration of the surrounding brain structures, but lack cerebrospinal or systemic metastases. In addition, they display
Autor:
Chie, Inomoto, Shigeyuki, Tahara, Kenichi, Oyama, Midori, Kimura, Akira, Matsuno, Akira, Teramoto, Robert Y, Osamura
Publikováno v:
Brain tumor pathology. 38(3)
In 2017, WHO published an updated classification of the pituitary adenomas according to the lineages defined by the transcription factors, PIT1, SF1 and TPIT. Nomenclature of the pituitary tumors follows the mature cell types such as somatotroph (GH)